George K. Ng, CEO of Processa Pharmaceuticals (NASDAQ:PCSA), purchased shares of the company's common stock on April 15, 2026.
He bought 1,843 shares at $2.97 each, totaling $5,473. The stock currently trades at $2.61, down 87% from its 52-week high of $19.63.
After the transaction, Ng directly holds 3,979 shares and indirectly holds shares through various entities.
The information was disclosed in an amended Form 4 filing with the SEC.












